GT198 Is a Target of Oncology Drugs and Anticancer Herbs
Tumor angiogenesis is a hallmark of cancer. Therapeutic drug inhibitors targeting angiogenesis are clinically effective. We have previously identified GT198 (gene symbol PSMC3IP, also known as Hop2) as an oncoprotein that induces tumor angiogenesis in human cancers, including oral cancer. In this st...
Main Authors: | Junfeng Pang, Jie Gao, Liyong Zhang, Nahid F. Mivechi, Lan Ko |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Oral Health |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/froh.2021.679460/full |
Similar Items
-
Ilustración-DG198-201602
by: Pizarro Fletcher Daniela Maria, et al.
Published: (2020) -
Ilustración-DG198-201701
by: Herrera Camacho Jose Luis, et al.
Published: (2020) -
Ilustración-DG198-201702
by: Herrera Camacho Jose Luis, et al.
Published: (2020) -
Ilustración-DG198-201801
by: Jimenez Ugarte Elly Ursula, et al.
Published: (2020) -
Ilustración-DG198-201802
by: Herrera Camacho Jose Luis, et al.
Published: (2020)